Is this treatment safe
A recent review pointed out that GLP-1 drugs may reduce the incidence of glaucoma while increasing the risk for neovascular age-related macular degeneration ( BMC Ophthalmology, Jan
Additional pathologies are neurological deficiencies that include intellectual disability, hypotonia, seizures, and difficulty walking
The risk of the cancer returning in 5 years was 6.9% in patients on aromatase inhibitor treatment, in comparison to 10.1% receiving tamoxifen
Impact of GLP -1 drugs on snack food consumption GLP - 1 drug use results in a measurable shift in users consumption behavior, with an especially large impact on several snack food categories
CrossRef Chronic Inflammation and Immune Dysregulation in Metabolic-Dysfunction-Associated Steatotic Liver Disease Progression: From Steatosis to Hepatocellular Carcinoma Young-Min Jee, Jeong-Yoon Lee, Tom Ryu Biomedicines .2025